Payment overview · 2025
General Payments
$62.47
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kevin Cope, M.D
Allopathic & Osteopathic Physicians|Family Medicine · BROADALBIN, NY · NPI 1861498248
Verified facts
What the public records show
CMS Open Payments records show Kevin Cope, M.D received $62.47 in general payments during 2025 across 2 reported records.
Braeburn Inc. accounted for 50.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 27 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 51 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Braeburn Inc. | Unresolved — no canonical attribution shown | $31.31 | 50.1% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $31.16 | 49.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $62.47 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BRIXADI Normalized: brixadi |
Drug | Braeburn Inc. | $31.31 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $31.16 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
27 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
51 | 13 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 670 | 165 |
| Omeprazole | Omeprazole | 575 | 144 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 475 | 137 |
| Gabapentin | Gabapentin | 454 | 96 |
| Lisinopril | Lisinopril | 452 | 119 |
| Atorvastatin Calcium | Atorvastatin Calcium | 447 | 121 |
| Amlodipine Besylate | Amlodipine Besylate | 382 | 99 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 309 | 37 |
| Losartan Potassium | Losartan Potassium | 302 | 74 |
| Furosemide | Furosemide | 292 | 74 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 265 | 44 |
| Metformin Hcl | Metformin Hcl | 249 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 238 | 60 |
| Atenolol | Atenolol | 222 | 55 |
| Sertraline Hcl | Sertraline Hcl | 222 | 51 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 220 | 66 |
| Mirtazapine | Mirtazapine | 213 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 205 | 60 |
| Famotidine | Famotidine | 199 | 42 |
| Hydrochlorothiazide | Hydrochlorothiazide | 199 | 55 |
| Citalopram Hbr | Citalopram Hydrobromide | 169 | 39 |
| Tramadol Hcl | Tramadol Hcl | 165 | 55 |
| Trazodone Hcl | Trazodone Hcl | 163 | 35 |
| Clonazepam | Clonazepam | 161 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 160 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 155 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 155 | 38 |
| Eliquis | Apixaban | 150 | 39 |
| Pregabalin | Pregabalin | 148 | 22 |
| Prednisone | Prednisone | 146 | 75 |
| Metoprolol Tartrate | Metoprolol Tartrate | 142 | 37 |
| Lorazepam | Lorazepam | 133 | 38 |
| Escitalopram Oxalate | Escitalopram Oxalate | 127 | 29 |
| Amitriptyline Hcl | Amitriptyline Hcl | 126 | 24 |
| Ozempic | Semaglutide | 109 | 22 |
| Potassium Chloride | Potassium Chloride | 106 | 21 |
| Simvastatin | Simvastatin | 105 | 26 |
| Bupropion Xl | Bupropion Hcl | 104 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 97 | 36 |
| Cephalexin | Cephalexin | 90 | 50 |
| Montelukast Sodium | Montelukast Sodium | 85 | 24 |
| Ibuprofen | Ibuprofen | 83 | 25 |
| Azithromycin | Azithromycin | 77 | 57 |
| Doxycycline Hyclate | Doxycycline Hyclate | 77 | 55 |
| Allopurinol | Allopurinol | 74 | 23 |
| Buspirone Hcl | Buspirone Hcl | 72 | 13 |
| Fluconazole | Fluconazole | 72 | 36 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 71 | 12 |
| Cefuroxime | Cefuroxime Axetil | 70 | 51 |
| Lactulose | Lactulose | 66 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 65 | 14 |
| Donepezil Hcl | Donepezil Hcl | 62 | 17 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 60 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 60 | 11 |
| Zolpidem Tartrate | Zolpidem Tartrate | 60 | suppressed |
| Finasteride | Finasteride | 59 | 19 |
| Alendronate Sodium | Alendronate Sodium | 57 | suppressed |
| Nystatin | Nystatin | 57 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 56 | 13 |
| Celecoxib | Celecoxib | 52 | 11 |
| Pravastatin Sodium | Pravastatin Sodium | 52 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 51 | 13 |
| Synthroid | Levothyroxine Sodium | 51 | 13 |
| Hydrocortisone | Hydrocortisone | 49 | 19 |
| Meclizine Hcl | Meclizine Hcl | 49 | 22 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 48 | suppressed |
| Trulicity | Dulaglutide | 48 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 47 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | 16 |
| Constulose | Lactulose | 46 | 13 |
| Diazepam | Diazepam | 46 | 19 |
| Farxiga | Dapagliflozin Propanediol | 46 | 14 |
| Jardiance | Empagliflozin | 46 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 44 | 13 |
| Xarelto | Rivaroxaban | 43 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 42 | 12 |
| Fluocinonide | Fluocinonide | 42 | 23 |
| Spironolactone | Spironolactone | 41 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 40 | 14 |
| Metformin Hcl Er | Metformin Hcl | 40 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 40 | suppressed |
| Amoxicillin | Amoxicillin | 39 | 24 |
| Ramipril | Ramipril | 39 | suppressed |
| Carisoprodol | Carisoprodol | 38 | suppressed |
| Ondansetron Odt | Ondansetron | 38 | suppressed |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Baclofen | Baclofen | 37 | suppressed |
| Fenofibrate | Fenofibrate | 37 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | suppressed |
| Latanoprost | Latanoprost | 37 | suppressed |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 36 | suppressed |
| Irbesartan | Irbesartan | 36 | suppressed |
| Olanzapine | Olanzapine | 36 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 35 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 24 |
| Testosterone | Testosterone | 35 | suppressed |
| Alprazolam | Alprazolam | 34 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 31 | suppressed |
| Lacosamide | Lacosamide | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 24 |
| Enulose | Lactulose | 29 | suppressed |
| Nifedipine Er | Nifedipine | 29 | suppressed |
| Mounjaro | Tirzepatide | 28 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 28 | suppressed |
| Linzess | Linaclotide | 27 | suppressed |
| Valsartan | Valsartan | 27 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 27 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 26 | suppressed |
| Carvedilol | Carvedilol | 26 | suppressed |
| Ibu | Ibuprofen | 26 | 11 |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 24 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 24 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 23 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 23 | suppressed |
| Topiramate | Topiramate | 23 | suppressed |
| Itraconazole | Itraconazole | 22 | suppressed |
| Ezetimibe | Ezetimibe | 21 | suppressed |
| Glipizide | Glipizide | 21 | suppressed |
| Haloperidol | Haloperidol | 21 | suppressed |
| Methylphenidate Er | Methylphenidate Hcl | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Econazole Nitrate | Econazole Nitrate | 20 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 20 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 20 | suppressed |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 20 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Memantine Hcl | Memantine Hcl | 19 | suppressed |
| Mupirocin | Mupirocin | 19 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | suppressed |
| Torsemide | Torsemide | 19 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 19 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 18 | suppressed |
| Prolia | Denosumab | 18 | 12 |
| Sucralfate | Sucralfate | 18 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 17 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 16 | suppressed |
| Carbamazepine | Carbamazepine | 16 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Digoxin | Digoxin | 16 | suppressed |
| Meloxicam | Meloxicam | 16 | suppressed |
| Amantadine | Amantadine Hcl | 15 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Metronidazole | Metronidazole | 15 | 12 |
| Myrbetriq | Mirabegron | 15 | suppressed |
| Pentoxifylline | Pentoxifylline | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 15 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 14 | suppressed |
| Nateglinide | Nateglinide | 14 | suppressed |
| Scopolamine | Scopolamine | 14 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Erythromycin | Erythromycin Base | 13 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Invokana | Canagliflozin | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | suppressed |
| Naproxen | Naproxen | 13 | suppressed |
| Nitroglycerin | Nitroglycerin | 13 | 12 |
| Propranolol Hcl | Propranolol Hcl | 13 | suppressed |
| Topamax | Topiramate | 13 | suppressed |
| Zonisamide | Zonisamide | 13 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Januvia | Sitagliptin Phosphate | 12 | suppressed |
| Lyrica | Pregabalin | 12 | suppressed |
| Travoprost | Travoprost | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $62.47 · 2 records | Braeburn Inc. | BRIXADI, VRAYLAR | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error